share_log

Great Valley Advisor Group Inc. Raises Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Great Valley Advisor Group Inc. Raises Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

大谷顾问集团增持直觉外科公司股份(纳斯达克代码:ISRG)
Defense World ·  2022/09/29 06:22

Great Valley Advisor Group Inc. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 593.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,273 shares of the medical equipment provider's stock after acquiring an additional 4,513 shares during the quarter. Great Valley Advisor Group Inc.'s holdings in Intuitive Surgical were worth $1,058,000 at the end of the most recent reporting period.

据直觉外科公司在提交给美国证券交易委员会的最新Form 13F文件中称,该公司在第二季度增持了360股份,增持幅度为593.8%。该公司在本季度额外收购了4513股后,拥有这家医疗设备提供商的5273股股票。在最近一次报告期结束时,大谷顾问集团持有的直觉外科公司股份价值1,058,000美元。

A number of other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 28,519,307 shares of the medical equipment provider's stock worth $8,603,704,000 after acquiring an additional 457,262 shares during the period. BlackRock Inc. increased its position in shares of Intuitive Surgical by 0.5% during the first quarter. BlackRock Inc. now owns 26,660,811 shares of the medical equipment provider's stock worth $8,043,033,000 after acquiring an additional 122,151 shares during the period. State Street Corp increased its position in shares of Intuitive Surgical by 2.3% during the first quarter. State Street Corp now owns 15,182,214 shares of the medical equipment provider's stock worth $4,580,170,000 after acquiring an additional 347,468 shares during the period. Capital World Investors increased its holdings in Intuitive Surgical by 0.3% during the first quarter. Capital World Investors now owns 9,687,380 shares of the medical equipment provider's stock valued at $2,922,569,000 after buying an additional 28,839 shares during the period. Finally, Edgewood Management LLC increased its holdings in Intuitive Surgical by 20.3% during the first quarter. Edgewood Management LLC now owns 8,902,682 shares of the medical equipment provider's stock valued at $2,685,761,000 after buying an additional 1,504,353 shares during the period. 82.44% of the stock is owned by hedge funds and other institutional investors.

其他一些机构投资者也调整了对该股的持有量。先锋集团第一季度增持直觉外科公司股票1.6%。先锋集团在此期间增持了457,262股,现在拥有28,519,307股这家医疗设备供应商的股票,价值8,603,704,000美元。今年第一季度,贝莱德增持了直觉外科公司的股票,增幅为0.5%。贝莱德股份有限公司在此期间增持了122,151股,目前持有26,660,811股这家医疗设备供应商的股票,价值8,043,033,000美元。道富银行在第一季度增持了直觉外科公司的股票,增幅为2.3%。道富集团目前持有这家医疗设备提供商15,182,214股票,价值4,580,170,000美元,在此期间额外收购了347,468股票。资本世界投资者在第一季度增持了直觉外科公司0.3%的股份。Capital World Investors现在拥有这家医疗设备提供商的9,687,380股票,价值2,922,569,000美元,在此期间又购买了28,839股票。最后,Edgewood Management LLC在第一季度增持了20.3%的直觉外科公司股份。Edgewood Management LLC现在拥有这家医疗设备提供商8,902,682股股票,价值2,685,761,000美元,在此期间又购买了1,504,353股。82.44%的股票由对冲基金和其他机构投资者持有。

Get
到达
Intuitive Surgical
直觉外科公司
alerts:
警报:

Intuitive Surgical Stock Performance

直觉外科公司股票表现

ISRG opened at $192.40 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $184.94 and a fifty-two week high of $369.69. The company has a fifty day moving average of $217.44 and a two-hundred day moving average of $231.36. The stock has a market capitalization of $68.71 billion, a price-to-earnings ratio of 48.96, a PEG ratio of 5.36 and a beta of 1.31.

ISRG周四开盘报192.40美元。直觉外科公司的股价为184.94美元,为52周低点,52周高点为369.69美元。该公司的50日移动均线切入位在217.44美元,200日移动均线切入位在231.36美元。该股市值687.1亿美元,市盈率为48.96倍,市盈率为5.36倍,贝塔系数为1.31。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 EPS for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. The company had revenue of $1.52 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the prior year, the firm earned $1.42 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 3.76 earnings per share for the current year.
直觉外科公司(纳斯达克代码:ISRG-GET Rating)最近一次发布收益报告是在7月21日星期四。这家医疗设备供应商公布本季度每股收益为0.85美元,低于分析师普遍预期的1.04美元(0.19美元)。直觉外科公司的股本回报率为12.04%,净利润率为24.05%。该公司当季营收为15.2亿美元,高于分析师预期的15.6亿美元。去年同期,该公司每股收益为1.42美元。股票研究分析师平均预测,直觉外科公司公司本年度每股收益为3.76欧元。

Insider Buying and Selling at Intuitive Surgical

直觉外科公司的内幕买卖

In other news, Director Amal M. Johnson sold 6,375 shares of the company's stock in a transaction that occurred on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total value of $1,517,505.00. Following the transaction, the director now directly owns 11,224 shares in the company, valued at approximately $2,671,760.96. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CEO Gary S. Guthart sold 79,412 shares of the stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $216.30, for a total transaction of $17,176,815.60. Following the completion of the sale, the chief executive officer now owns 54,607 shares in the company, valued at approximately $11,811,494.10. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 6,375 shares of the firm's stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now owns 11,224 shares of the company's stock, valued at approximately $2,671,760.96. The disclosure for this sale can be found here. Insiders have sold 101,162 shares of company stock worth $22,062,916 in the last ninety days. 0.90% of the stock is owned by insiders.

其他新闻方面,董事在8月3日星期三的一笔交易中出售了6,375股该公司股票。这些股票的平均价格为238.04美元,总价值为1,517,505.00美元。交易完成后,董事现在直接拥有该公司11,224股股份,价值约2,671,760.96美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过此超链接。在相关新闻中,首席执行官加里·S·古萨特在7月26日星期二的一次交易中出售了79,412股该公司股票。这些股票的平均价格为216.30美元,总成交金额为17,176,815.60美元。出售完成后,首席执行官现在拥有公司54,607股,价值约11,811,494.10美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过美国证券交易委员会网站。此外,在8月3日星期三的一笔交易中,董事出售了6,375股该公司股票。股票以238.04美元的平均价格出售,总成交金额为1,517,505.00美元。出售完成后,董事现在拥有11,224股该公司股票,价值约2,671,760.96美元。关于这次销售的披露可以找到这里。在过去的90天里,内部人士卖出了101,162股公司股票,价值22,062,916美元。该公司0.90%的股份由内部人士持有。

Analysts Set New Price Targets

分析师设定新的价格目标

Several equities analysts recently issued reports on the stock. Stifel Nicolaus lifted their price objective on shares of Intuitive Surgical from $250.00 to $260.00 and gave the company a "buy" rating in a report on Friday, September 9th. Morgan Stanley cut their price objective on shares of Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating on the stock in a report on Friday, July 15th. Raymond James cut their price objective on shares of Intuitive Surgical from $294.00 to $255.00 in a report on Friday, July 22nd. The Goldman Sachs Group cut their price objective on shares of Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating on the stock in a report on Friday, July 29th. Finally, Wells Fargo & Company cut their price objective on shares of Intuitive Surgical to $265.00 in a report on Friday, July 22nd. Six equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $268.00.

几位股票分析师最近发布了有关该股的报告。9月9日,Stifel Nicolaus在一份报告中将直觉外科公司股票的目标价从250.00美元上调至260.00美元,并给予该公司“买入”评级。摩根士丹利在7月15日星期五的一份报告中将直觉外科公司的目标股价从300.00美元下调至225.00美元,并对该股设定了“同等权重”的评级。雷蒙德·詹姆斯在7月22日星期五的一份报告中将直觉外科公司的股价目标从294.00美元下调至255.00美元。高盛夫妇在7月29日星期五的一份报告中将直觉外科公司的股票目标价从319.00美元下调至273.00美元,并对该股设定了“买入”评级。最后,富国银行在7月22日星期五的一份报告中将直觉外科公司的股票目标价下调至265.00美元。6名股票研究分析师对该股的评级为持有,12名分析师对该公司的评级为买入。根据MarketBeat的数据,该股目前的平均评级为“适度买入”,共识目标价为268.00美元。

Intuitive Surgical Profile

直觉外科公司简介

(Get Rating)

(获取评级)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

直觉外科公司公司开发、制造和营销产品,使医生和医疗保健提供者能够在美国和国际上提高微创护理的质量和获得微创护理的机会。该公司提供达芬奇外科系统,以实现使用微创方法进行复杂手术;以及离子腔内系统,将其商业产品从外科扩展到能够进行微创肺活组织检查的诊断程序。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • A Trio of Q3 Winners With Room to Run
  • This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
  • Can HCA Healthcare Weather the Normalization?
  • Can United Natural Foods Fight Both Inflation and the Fed?
  • Mullen Automotive Is Ready To Get In Gear
  • 免费获取斯托克新闻网关于直觉外科公司的研究报告
  • 第三季度赢家三人组还有运行的空间
  • 这个小知名的小盘股上涨了139%:这只股票是买入的吗?
  • HCA医疗能否经受住正常化的考验?
  • 联合天然食品能同时对抗通胀和美联储吗?
  • 马伦汽车已做好准备投入使用

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《直觉外科公司日报》的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯接收对直觉外科公司及相关公司的最新新闻和分析师评级的每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发